January 4, 2017
GlucoSentient has recently awarded two SBIR Phase I awards for developing point-of-care solution for invasive fungal infections and therapeutic drug monitoring for bipolar disorder.
October 1, 2013
GlucoSentient receives NSF Phase II SBIR grant to continue work on Therapeutic Drug Monitoring.
July 1, 2013
GlucoSentient receives Phase I NIH SBIR award for work in Disease Monitoring.
April 1, 2013
Tian Lan and GlucoSentient receives the NIH SHIFT Award!
October 16, 2012
GlucoSentient completes seed financing
July 1, 2012
GlucoSentient receives Phase I NSF SBIR award for work in Therapeutic Drug Monitoring.
April 10, 2012
GlucoSentient presents at Share the Vision 2012 Technology Showcase at EnterpriseWorks
March 31, 2012
GlucoSentient wins “Best Digital Health Application” 2012 Cozad New Venture Competition! Thanks to Burrill & Company for sponsoring the prize. [Article]
March 20, 2012
Antibody-based assays using personal glucose meters (PGM) published in Analytical Chemistry. [Link]
December 14, 2011
GlucoSentient team graduates from I-CORPS!